vorinostat has been researched along with Stress Disorders, Post-Traumatic in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Stress Disorders, Post-Traumatic: A class of traumatic stress disorders with symptoms that last more than one month.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vorinostat was intraperitoneally injected immediately after second extinction training session." | 1.39 | Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder. ( Fujita, Y; Matsumoto, T; Matsumoto, Y; Morinobu, S; Takei, S; Yamamoto, S; Yamawaki, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, Y | 1 |
| Morinobu, S | 2 |
| Yamamoto, S | 2 |
| Matsumoto, T | 1 |
| Takei, S | 1 |
| Fujita, Y | 2 |
| Yamawaki, S | 1 |
1 review available for vorinostat and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
[Novel therapeutic approach for the treatment of post-traumatic stress disorder (PTSD): facilitating fear extinction].
Topics: Acetyltransferases; Animals; Extinction, Psychological; Fear; Hydroxamic Acids; Male; Rats; Receptor | 2012 |
1 other study available for vorinostat and Stress Disorders, Post-Traumatic
| Article | Year |
|---|---|
Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Extinction, Psy | 2013 |